13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001201001
Total reported value
$170.0M
$170.0M
9 檔
120.2%
As reported in its official Q3 2025 Form 13F filing, Harbourvest Partners LLC's tracked investment portfolio stood at $170.0M with 9 total positions.
In Q3 2025, Harbourvest Partners LLC adopted a defensive or profit-taking posture, trimming 1 positions and completely liquidating 10 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | KLAR | Klarna Group plc | Stock-Other | 89.77% | -5.38% | — | |
| 2 | YMM | Full Truck Alliance -spn Adr | Stock-Other | 6.06% | -3.31% | — | |
| 3 | CAMP | Camp4 Therapeutics CORP | Stock-Other | 1.86% | -2.29% | — | |
| 4 | ✓ | Pagaya Technologies LTD Cl | Stock-Other | 1.63% | — | — | |
| 5 | RKLB | Rocket Lab CORP | Stock-Industrials | 0.35% | — | — | |
| 6 | U | Unity Software Inc | Stock-Tech | 0.18% | — | -72.97% | |
| 7 | SONDQ | Sonder Holdings Inc | Stock-Other | 0.14% | — | — | |
| 8 | RPTX | Repare Therapeutics Inc | Stock-Other | 0.01% | — | — | |
| 9 | IPSC | Century Therapeutics Inc | Stock-Other | 0.01% | -0.02% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | RPTX | Repare Therapeutics Inc | — | — | Unchanged |
| 2 | IPSC | Century Therapeutics Inc | — | — | Unchanged |
| 3 | SONDQ | Sonder Holdings Inc | -0.2% | — | Unchanged |
| 4 | U | Unity Software Inc | -0.3% | -72.97% | Trim |
| 5 | CAMP | Camp4 Therapeutics CORP | -1.5% | — | Unchanged |
| 6 | YMM | Full Truck Alliance -spn Adr | -1.9% | — | Unchanged |
| 7 | KLAR | Klarna Group plc | — | NEW | New buy |
| 8 | TTAN | Servicetitan Inc-a | — | EXIT | Sold out |
| 9 | W | Wayfair Inc- Class A | — | EXIT | Sold out |
| 10 | RBRK | Rubrik Inc-a | — | EXIT | Sold out |
| 11 | ✓ | Pagaya Technologies LTD Cl | — | NEW | New buy |
| 12 | HAPN | Happen Inc | — | EXIT | Sold out |
| 13 | AMPL | Amplitude Inc-class A | — | EXIT | Sold out |
| 14 | OKLO | Oklo Inc | — | EXIT | Sold out |
| 15 | RLAY | Relay Therapeutics Inc | — | EXIT | Sold out |
| 16 | RKLB | Rocket Lab CORP | — | NEW | New buy |
| 17 | DIBS | 1stdibs.com Inc | — | EXIT | Sold out |
| 18 | ✓ | Neuehealth Inc | — | EXIT | Sold out |
| 19 | OPEN | Opendoor Technologies Inc | — | EXIT | Sold out |
According to official SEC Form 13F filings, Harbourvest Partners LLC reported a total U.S. public equity portfolio value of $170.0M across 9 disclosed positions in Q3 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including KLAR, YMM, CAMP) accounted for 120.2% of total reported equity market value during Q3 2025.
Top New Position Initiated
KLAR
市值: $184.1M
Top Position Liquidated / Trimmed
TTAN
前期市值: $84.3M
During Q3 2025, Harbourvest Partners LLC's top holdings by market value included KLAR (89.8%)、YMM (6.1%)、CAMP (1.9%). The largest single position, KLAR, represented 89.8% of total portfolio value.
In Q3 2025, Harbourvest Partners LLC made 14 total portfolio adjustments, initiating 3 new buys, adding to 0 positions, trimming 1 holdings, and fully liquidating 10 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.